Gilead Sciences, Inc. has received conditional marketing authorization from the European Commission (EC) for Seladelpar for the treatment of primary biliary cholangitis (PBC) ...
The American quant hedge fund Renaissance Technologies is known for using statistical and mathematical tools to drive its ...
Approved, Seladelpar Can Provide an Important Treatment Option for People Living With the Rare Liver Disease in the European Economic Area – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback